Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...

What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...

The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company’s MHC Class II agonist, eftilagimod alfa (efti) in combination with MSD’s (Merck & ...

Six William & Mary geology students presented their research, receiving valuable feedback from experts, while faculty highlighted the importance of this event for collaboration in the field.

SXSW 2025 delivers a star-studded lineup, featuring red carpet premieres and gala events celebrating cinematic figures and up ...

Miss Universe Thailand’s Facebook announcement offering a dinner with Victoria Kjær Theilvig, the 2024 Miss Universe ...

The CARAai platform supports a wide range of enterprise healthcare and life sciences use cases and solutions. Over the course of 2025, ConcertAI will be launching a series of new AI SaaS solutions ...

Dr. Laila El-Khattabi (Sorbonne University Hospitals and the Brain Institute, Paris, France) will share results from the CHROMAPS project, a multi-institutional European collaboration utilizing OGM to ...

Xentria, a clinical-stage biopharmaceutical company advancing therapies for rare and serious diseases, today announced the successful completion of enrollment in the therapeutic dose-ranging phase of ...

The chatter that has dominated both coffee-break discussions and high-level pronouncements at the 69th session of the Commission on the Status of Women (CSW) is of a global and orchestrated “backlash” ...